B1

Nuntium

Global Medechus C album dimisit

Contra backdrop de celeri progressionem global medicinae technology, quod est crucial intelligere progressionem dynamics et innovative products de industria scriptor ducit societates. Previously, magis influentiave transmarinas lists (MEDTECH Big C, Top C Medical cogitationes, medicinae cogitationes XXV, etc.) Non comprehensively includitur Seres turmas in statistics. Ideo, siiyu Medtech habet developed in global Medechus Top C List secundum in MMXXII Financial Renuntiationes ex enumerantur societates in variis regiones ut dimisit in MMXXIII.

微信截图 _20231218090420

.

Hoc album est unique et scientific in eo includit optimum faciendo medicinae fabrica turmas worldwide:

Et inclusion of enumerantur Medical fabrica societates ex Sinis praebet comprehensive picture de Sinis scriptor situ et influentiam in global medicinae fabrica industria.
Data source and calculation method of the list: Calculated based on the revenue in the 2022 financials released by each company before 30 October 2023 For some of the large integrated groups, only the annual revenue of the medical device section of the business is calculated; In altiore diaphanum et reliability de data est. (Ob diversas requisita pro enumerantur turmas in diversis regionibus, in leo de fiscali anni non est idem, quod haec ad exigere simul reditus.)
Nam definitio medicinae cogitationes, fundatur in Sinis scriptor ordinationes super vigilantia et administratione medicinae cogitationes.

Special Nota: Seres Companies in hoc album includit:

Myriad Medical (33rd), Jiuan Medical (40th), Weigao Group (61st) Daan Genetics (64th), Lepu Medical (66th), Medical Stable Medical (81st), Yuyue Medical (82nd), Kewa Biotech (84th), Xinhua Medical (85th), Inventeec Medical (87th), Hengxiang (91st), Anxu Biotechnology (91st), Wicresoft (91st (91st), Wicresoft Medical (92nd ) Zhende Medical (93rd), wanfu biotechnology (95th), kepu biootechnology (96th), Shuoshi Biootechnology (97th), et Lashan Medical (100).

Secundum ad MMXXIII Global Medech Top100, Medical fabrica societates habent sequentes,

Revenue distribution habet inaequalis: X% de societatibus in list habere reditus in $ C billion, LIV% sunt infra $ X billion, et LXXV% sunt infra $ XL billion, plene reflectitur attributa de medical fabrica industria.

 

Geographic trustering effectus sunt;

Civitatibus Foederatis Americae est in domum suam ad XL per cent of turmas in album; Maturitatem eius medterech foro, sua facultatem ad technicae innovation, et ejus princeps acceptatio novi products contribuere ad Vibrant innovation environment.

Sinis sequitur cum XVII per cent of enumerantur societatibus, headquarters; Non beneficia a patriae consilium auxilium, crescente foro demanda, et vires in productione et supplere catenam.

De particularibus note sunt Helvetia et Denmark, duo parva terris cum quattuor firms uterque sunt altus specialioribus et competitive in specifica foro segments.

 

 


Post tempus: Dec 18-2023